Literature DB >> 8763265

HPV testing in patients with low grade cervical cytological abnormalities: a follow up study.

C S Herrington1, M F Evans, F M Charnock, W Gray, J O'D McGee.   

Abstract

AIM: To assess the diagnostic performance of human papillomavirus (HPV) analysis in predicting cervical intraepithelial neoplasia (CIN) grades 2 and 3 in patients with persistent low grade cervical cytological abnormalities.
METHODS: Cervical smears from 167 women referred for colposcopy with persistent borderline, wart virus or mildly dyskaryotic changes on cervical screening were analysed by Papanicolaou staining, non-isotopic in situ hybridisation and generic and type specific polymerase chain reaction (PCR) amplification of HPV sequences. Follow up was by cytological and, where appropriate, histological analysis.
RESULTS: CIN grade 2 or 3 was identified in 46 patients after a median follow up of 27 months. HPV positivity by both techniques was associated with high grade CIN and with age less than 30 years (median age 33 years). Non-isotopic in situ hybridisation was more predictive but less sensitive than either generic or type specific PCR, but prediction was greater using either molecular technique in women over 30 years of age.
CONCLUSIONS: Although the degree of prediction found is of only limited clinical value, the strong association of HPV positivity with both high grade CIN and patient age suggests that further studies of HPV testing in this patient group are warranted.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8763265      PMCID: PMC500541          DOI: 10.1136/jcp.49.6.493

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

Review 1.  Detection of human papillomavirus in cervical scrapes by the polymerase chain reaction in relation to cytology: possible implications for cervical cancer screening.

Authors:  C J Meijer; A J van den Brule; P J Snijders; T Helmerhorst; P Kenemans; J M Walboomers
Journal:  IARC Sci Publ       Date:  1992

Review 2.  Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia.

Authors:  M H Schiffman
Journal:  J Natl Cancer Inst       Date:  1992-03-18       Impact factor: 13.506

Review 3.  Human papillomaviruses and cervical neoplasia. I. Classification, virology, pathology, and epidemiology.

Authors:  C S Herrington
Journal:  J Clin Pathol       Date:  1994-12       Impact factor: 3.411

4.  Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance.

Authors:  J T Cox; A T Lorincz; M H Schiffman; M E Sherman; A Cullen; R J Kurman
Journal:  Am J Obstet Gynecol       Date:  1995-03       Impact factor: 8.661

5.  Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia.

Authors:  M H Schiffman; H M Bauer; R N Hoover; A G Glass; D M Cadell; B B Rush; D R Scott; M E Sherman; R J Kurman; S Wacholder
Journal:  J Natl Cancer Inst       Date:  1993-06-16       Impact factor: 13.506

6.  Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia.

Authors:  G Y Ho; R D Burk; S Klein; A S Kadish; C J Chang; P Palan; J Basu; R Tachezy; R Lewis; S Romney
Journal:  J Natl Cancer Inst       Date:  1995-09-20       Impact factor: 13.506

7.  Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types.

Authors:  A T Lorincz; R Reid; A B Jenson; M D Greenberg; W Lancaster; R J Kurman
Journal:  Obstet Gynecol       Date:  1992-03       Impact factor: 7.661

8.  Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report.

Authors:  P J Bavin; J A Giles; A Deery; J Crow; P D Griffiths; V C Emery; P G Walker
Journal:  Br J Cancer       Date:  1993-03       Impact factor: 7.640

9.  Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia.

Authors:  J Cuzick; G Terry; L Ho; T Hollingworth; M Anderson
Journal:  Br J Cancer       Date:  1994-01       Impact factor: 7.640

10.  Human papillomavirus status in the prediction of high-grade cervical intraepithelial neoplasia in patients with persistent low-grade cervical cytological abnormalities.

Authors:  C S Herrington; M F Evans; N F Hallam; F M Charnock; W Gray; J D McGee
Journal:  Br J Cancer       Date:  1995-01       Impact factor: 7.640

View more
  2 in total

1.  Comparison between the Hybrid Capture II Test and an SPF1/GP6+ PCR-based assay for detection of human papillomavirus DNA in cervical swab samples.

Authors:  Shang-Lang Huang; Angel Chao; Swei Hsueh; Fang-Yu Chao; Chu-Chun Huang; Jung-Erh Yang; Ching-Yu Lin; Chiu-Cho Yan; Hung-Hsueh Chou; Kuan-Gen Huang; Huei-Jean Huang; Tzu-I Wu; Mao-Jung Tseng; Jian-Tai Qiu; Cheng-Tao Lin; Ting-Chang Chang; Chyong-Huey Lai
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

2.  Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.

Authors:  C L Peyton; M Schiffman; A T Lörincz; W C Hunt; I Mielzynska; C Bratti; S Eaton; A Hildesheim; L A Morera; A C Rodriguez; R Herrero; M E Sherman; C M Wheeler
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.